Mitomycin is a chemotherapy drug used to treat various cancers. However, during the manufacturing process of Mitomycin, impurities may be introduced that can affect the drug's purity, efficacy and safety. These impurities can include degradation products, related compounds, and residual solvents. It is important to closely monitor and control the levels of these impurities to ensure the quality of the drug product.
